Other known modifiers of DMD muscle pathology, such as osteopontin and LTBP4, are involved in pro-fibrotic signaling, and their reduction diminishes fibrosis and improves muscle pathology83–85. The gene discussed is LTBP4; the disease is Duchenne muscular dystrophy.